Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin

Journal of Neuroendocrinology

Volumn 8, Issue 8, 1996, Pages 587-593

  Scarceriaux V ^a   Souaze F ^a   Bachelet, C M ^a   Forgez, P ^a   Bourdel, E ^b   Martinez, J ^b   Rostène, William ^a   Pelaprat D ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b CNRS   (France)

Author keywords

Cell cultures; Dexamethasone; Forskolin; Hypothalamus; Neurotensin receptor; Receptor regulation

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; ANTIBODY; DEXAMETHASONE; FORSKOLIN; GLUCOCORTICOID; MESSENGER RNA; NEUROTENSIN; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CELL CULTURE; CONTROLLED STUDY; FETUS; HYPOTHALAMUS; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0029778099     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.1996.tb00692.x     Document Type: Article

References (41)

1. Carraway RE, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973; 248: 6854-6861.
2. Kobayashi R, Brown M, Vale W. Regional distribution of neurotensin and somatostatin in rat brain. Brain Res 1977; 126: 584-588.
3. Fuxe K, Agnati L, Andersson K et al. Studies on neurotensin-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Neurochem Int 1984; 6: 737-750.
4. Vijayan E, McCann SM. Physiological significance of neurotensin in pituitary glycoprotein hormone release as revealed by in vivo and in vitro studies with neurotensin antiserum. Neuroendocrinology 1994; 60: 157-164.
5. Kitabgi P, Checler F, Mazella J, Vincent JP. Pharmacology and biochemistry of neurotensin receptors. Re v Clin Basic Pharmacol 1985; 5: 397-486.
6. Nicot A, Bérod A, Gully D et al. Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology 1994; 59: 572-578.
7. Tanaka K, Masu M, Nakanishi S. Structure and functional expression of cloned rat neurotensin receptor. Neuron 1990; 4: 847-854.
8. Poustis C, Mazella J, Kitabgi P, Vincent JP. High-affinity neurotensin binding sites in differentiated neuroblastoma N1E-115 cells. J Neurochem 1984; 42: 1094-1100.
9. Kitabgi P, Poustis C, Granier C et al. Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure-activity relationships. Mol Pharmacol 1980; 18: 11-19.
10. Dana C, Pélaprat D, Vial M et al. Characterization of neurotensin binding sites on rat mesencephalic cells in primary culture. Dev Brain Res 1991; 61: 259-264.
11. Vanisberg MA, Maloteaux JM, Octave JN et al. Rapid agonist-induced decrease of neurotensin receptors from the cell surface in rat cultured neurons. Biochem Pharmacol 1991; 42: 2265-2274.
12. 3-neurotensin. Neuroscience 1987; 22: 525-536.
13. Elde R, Schalling M, Ceccatelli S et al. Localization of neuropeptide mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors. Neurosci Lett 1990; 120: 134-138.
14. Nicot A, Rostène W, Bérod A. Neurotensin receptor expression in the rat forebrain and midbrain: a combined analysis by in situ hybridization and receptor autoradiography study. J Comp Neurol 1994; 344: 407-419.
15. Palacios JM, Pazos A, Dietl MM et al. The ontogeny of brain neurotensin receptors studied by autoradiography. Neuroscience 1988; 25: 307-317.
16. Sato M, Kiyama H, Tohyama M. Different postnatal development of cells expressing mRNA encoding neurotensin receptor. Neuroscience 1992; 48: 137-149.
17. Scarcériaux V, Pélaprat D, Lhiaubet AM et al. Development pattern of neurotensin content in rat hypothalamic neurons cultured in serum-free medium: comparison with in vivo data. Dev Brain Res 1994; 81: 128-130.
18. Scarcériaux V, Pélaprat D, Forgez P et al. Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures. Endocrinology 1995; 136: 2554-2560.
19. Alexander MJ. Estrogen-regulated synthesis of neurotensin in neuro-secretory cells of the hypothalamic arcuate nucleus in the female rat. Endocrinology 1993; 133: 1809-1816.
20. 125l-neurotensin in rat suprachiasmatic nucleus. Neuroendocrinology 1988; 48: 53-60.
21. Rowe W, Viau V, Meaney MJ et al. Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: Evidence for the participation of the paraventricular nucleus. J Neuroendocrinology 1995; 7: 109-117.
22. Sadoul JL, Mazella J, Amar S et al. Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. Biochem Biophys Res Commun 1984; 120: 812-819.
23. Brouard A, Pélaprat D, Dana C et al. Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors. J Neuroscience 1992; 12: 1409-1415.
24. Mak JCW, Nishikawa M, Barnes PJ. Glucocorticoids increase β2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 268: L41-L46.
25. Kiely J, Hadcock JR, Bahouth SW et al. Glucocorticoids down-regulate beta(1)-adrenergic-receptor expression by suppressing transcription of the receptor gene. Biochem J 1994; 302: 397-403.
26. Zacharias U, Xu Y, Hagège J et al. Thrombin, phorbol ester, and cAMP regulate thrombin receptor protein and mRNA expression by different pathways. J Biol Chem 1995; 270: 545-550.
27. Lee NH, Fraser CM. Cross-talk between m1 muscarinic acetylcholine and β-2 adrenergic receptors. J Biol Chem 1993; 268: 7949-7957.
28. Turner JT, James-Kracke MR, Camden JM. Regulation of the neurotensin receptor and intracellular calcium mobilization in HT 29 cells. J Pharmacol Exp Ther 1990; 253: 1049-1056.
29. Yamada M, Yamada M, Watson MA et al. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. Mol Pharmacol 1993; 46 470-476.
30. Di Paola ED, Cusack B, Yamada M et al. Desensitization and down- regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8]neurotensin (8-13). J Pharmacol Exp Ther 1993; 264: 1-5.
31. Hadcock JR, Malbon CC. Down-regulation of adrenergic receptors agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA 1988; 298: 163-165.
32. Azzi M, Nicot A, Gully D et al. Increase in neurotensin receptor in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692. Neurosci Lett 1994; 172: 97-100.
33. Faivre-Bauman A, Puymirat J, Loudes C et al. Differentiated mouse fetal hypothalamic cells in serum-free medium. In: Alan R. Liss, eds. Methods for serum-free culture of neuronal and lymphoid cells. New York; 1984: 37-56.
34. Checler F, Mazella J, Kitabgi P et al. High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons. J Neurochem 1986; 47: 1742-1748.
35. Dobner PR, Barber DL, Villa-Komarorf L et al. Cloning and sequencing of cDNA for the canine neurotensin/neuromedin N precursor. Proc Natl Acad Sci. USA 1987; 84: 3516-3520.
36. Dubuc I, Costentín J, Doulut S et al. JMV 449: a pseudopeptide analogue of neurotensin 8-13 with highly potent and long-lasting hypothermie and analgesic effects in the mouse. Eur J Pharmacol 1992; 219: 327-329.
37. Gully D, Canton M, Boigegrain R et al. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci. USA 1993; 90: 65-69.
38. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand binding systems. Analytic Biochem 1980; 107: 220-226.
39. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
40. Aviv H, Leder P. Purification of biological active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci. USA 1972; 69: 1408-1412.
41. Nagano M, Kelly PA. Tissue distribution and regulation of rat prolactin receptor gene expression. J Biol Chem 1994; 269: 13337-13345.